Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure

Environ Mol Mutagen. 1996;28(4):424-9. doi: 10.1002/(SICI)1098-2280(1996)28:4<424::AID-EM18>3.0.CO;2-H.

Abstract

1,3-Butadiene (BD) is a carcinogen that is bioactivated to at least two genotoxic metabolites. In the present article, we review briefly our previous studies on the in vivo mutagenicity and mutational spectra of BD in bone marrow and extend these studies to examine the effect of exposure time (5-days vs. 4-week exposure to 625 ppm BD used in previous studies) on the lacI mutant frequency in the bone marrow. Inhalation exposure to BD at 625 ppm and 1,250 ppm mutagenic in vivo, inducing an increase in the transgene mutant and mutation frequency in the bone marrow. Analysis of the mutational spectrum in BD-exposed and air control mice demonstrated that BD exposure induced an increased frequency of mutations at A:T base pairs. There was no difference in the lacI mutant frequency determined in the bone marrow between a short-term exposure to BD (5 days) and a longer-term exposure (4 weeks). These data taken together demonstrate that inhalation exposure to BD induces in vivo somatic cell mutation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Inhalation
  • Animals
  • Bacterial Proteins / drug effects
  • Bacterial Proteins / genetics*
  • Bone Marrow / drug effects*
  • Butadienes / administration & dosage
  • Butadienes / toxicity*
  • Escherichia coli Proteins*
  • Lac Repressors
  • Male
  • Mice
  • Mice, Transgenic
  • Mutagenicity Tests
  • Mutagens / toxicity
  • Mutation / drug effects*
  • Repressor Proteins / drug effects
  • Repressor Proteins / genetics*
  • Time Factors

Substances

  • Bacterial Proteins
  • Butadienes
  • Escherichia coli Proteins
  • Lac Repressors
  • Mutagens
  • Repressor Proteins
  • 1,3-butadiene